A citation-based method for searching scientific literature

R Ross. N Engl J Med 1999
Times Cited: 16312







List of co-cited articles
345 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
Paul M Ridker, Brendan M Everett, Tom Thuren, Jean G MacFadyen, William H Chang, Christie Ballantyne, Francisco Fonseca, Jose Nicolau, Wolfgang Koenig, Stefan D Anker,[...]. N Engl J Med 2017
22

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.
Jean-Claude Tardif, Simon Kouz, David D Waters, Olivier F Bertrand, Rafael Diaz, Aldo P Maggioni, Fausto J Pinto, Reda Ibrahim, Habib Gamra, Ghassan S Kiwan,[...]. N Engl J Med 2019
819
14

Colchicine in Patients with Chronic Coronary Disease.
Stefan M Nidorf, Aernoud T L Fiolet, Arend Mosterd, John W Eikelboom, Astrid Schut, Tjerk S J Opstal, Salem H K The, Xiao-Fang Xu, Mark A Ireland, Timo Lenderink,[...]. N Engl J Med 2020
384
12


Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.
Paul M Ridker, Brendan M Everett, Aruna Pradhan, Jean G MacFadyen, Daniel H Solomon, Elaine Zaharris, Virak Mam, Ahmed Hasan, Yves Rosenberg, Erin Iturriaga,[...]. N Engl J Med 2019
526
10

Immunity and Inflammation in Atherosclerosis.
Dennis Wolf, Klaus Ley. Circ Res 2019
356
9

Inflammation in atherosclerosis: from pathophysiology to practice.
Peter Libby, Paul M Ridker, Göran K Hansson. J Am Coll Cardiol 2009
8

Mechanisms of plaque formation and rupture.
Jacob Fog Bentzon, Fumiyuki Otsuka, Renu Virmani, Erling Falk. Circ Res 2014
907
7

Low-dose colchicine for secondary prevention of cardiovascular disease.
Stefan M Nidorf, John W Eikelboom, Charley A Budgeon, Peter L Thompson. J Am Coll Cardiol 2013
468
6

Atherosclerosis.
Peter Libby, Julie E Buring, Lina Badimon, Göran K Hansson, John Deanfield, Márcio Sommer Bittencourt, Lale Tokgözoğlu, Eldrin F Lewis. Nat Rev Dis Primers 2019
570
6

Inflammation in atherosclerosis.
Peter Libby. Nature 2002
6

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
Paul M Ridker, Eleanor Danielson, Francisco A H Fonseca, Jacques Genest, Antonio M Gotto, John J P Kastelein, Wolfgang Koenig, Peter Libby, Alberto J Lorenzatti, Jean G MacFadyen,[...]. N Engl J Med 2008
6

Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation.
Kristiina Rajamäki, Jani Lappalainen, Katariina Oörni, Elina Välimäki, Sampsa Matikainen, Petri T Kovanen, Kari K Eklund. PLoS One 2010
592
5

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals.
Peter Duewell, Hajime Kono, Katey J Rayner, Cherilyn M Sirois, Gregory Vladimer, Franz G Bauernfeind, George S Abela, Luigi Franchi, Gabriel Nuñez, Max Schnurr,[...]. Nature 2010
5

Single-Cell RNA-Seq Reveals the Transcriptional Landscape and Heterogeneity of Aortic Macrophages in Murine Atherosclerosis.
Clément Cochain, Ehsan Vafadarnejad, Panagiota Arampatzi, Jaroslav Pelisek, Holger Winkels, Klaus Ley, Dennis Wolf, Antoine-Emmanuel Saliba, Alma Zernecke. Circ Res 2018
284
5

Macrophages in the pathogenesis of atherosclerosis.
Kathryn J Moore, Ira Tabas. Cell 2011
5

Local proliferation dominates lesional macrophage accumulation in atherosclerosis.
Clinton S Robbins, Ingo Hilgendorf, Georg F Weber, Igor Theurl, Yoshiko Iwamoto, Jose-Luiz Figueiredo, Rostic Gorbatov, Galina K Sukhova, Louisa M S Gerhardt, David Smyth,[...]. Nat Med 2013
647
5

Inflammation and atherosclerosis.
Peter Libby, Paul M Ridker, Attilio Maseri. Circulation 2002
5

The immune system in atherosclerosis.
Göran K Hansson, Andreas Hermansson. Nat Immunol 2011
5

Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association.
Emelia J Benjamin, Salim S Virani, Clifton W Callaway, Alanna M Chamberlain, Alexander R Chang, Susan Cheng, Stephanie E Chiuve, Mary Cushman, Francesca N Delling, Rajat Deo,[...]. Circulation 2018
5

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.
Brian A Ference, Henry N Ginsberg, Ian Graham, Kausik K Ray, Chris J Packard, Eric Bruckert, Robert A Hegele, Ronald M Krauss, Frederick J Raal, Heribert Schunkert,[...]. Eur Heart J 2017
5

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.
Frank L J Visseren, François Mach, Yvo M Smulders, David Carballo, Konstantinos C Koskinas, Maria Bäck, Athanase Benetos, Alessandro Biffi, José-Manuel Boavida, Davide Capodanno,[...]. Eur Heart J 2021
196
5

Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis.
Michael A Gimbrone, Guillermo García-Cardeña. Circ Res 2016
4


Vascular smooth muscle cells in atherosclerosis.
Gemma L Basatemur, Helle F Jørgensen, Murray C H Clarke, Martin R Bennett, Ziad Mallat. Nat Rev Cardiol 2019
279
4

The role of B cells in atherosclerosis.
Andrew P Sage, Dimitrios Tsiantoulas, Christoph J Binder, Ziad Mallat. Nat Rev Cardiol 2019
94
4

Progress and challenges in translating the biology of atherosclerosis.
Peter Libby, Paul M Ridker, Göran K Hansson. Nature 2011
4

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.
Thomas A Pearson, George A Mensah, R Wayne Alexander, Jeffrey L Anderson, Richard O Cannon, Michael Criqui, Yazid Y Fadl, Stephen P Fortmann, Yuling Hong, Gary L Myers,[...]. Circulation 2003
4

Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial.
David A Morrow, James A de Lemos, Marc S Sabatine, Stephen D Wiviott, Michael A Blazing, Amy Shui, Nader Rifai, Robert M Califf, Eugene Braunwald. Circulation 2006
234
4

Atherosclerosis. the road ahead.
C K Glass, J L Witztum. Cell 2001
4


Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association.
Salim S Virani, Alvaro Alonso, Hugo J Aparicio, Emelia J Benjamin, Marcio S Bittencourt, Clifton W Callaway, April P Carson, Alanna M Chamberlain, Susan Cheng, Francesca N Delling,[...]. Circulation 2021
890
4


Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction.
Kaspar Broch, Anne Kristine Anstensrud, Sindre Woxholt, Kapil Sharma, Ingvild Maria Tøllefsen, Bjørn Bendz, Svend Aakhus, Thor Ueland, Brage Høyem Amundsen, Jan Kristian Damås,[...]. J Am Coll Cardiol 2021
39
10

IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial.
Paul M Ridker, Matt Devalaraja, Florian M M Baeres, Mads D M Engelmann, G Kees Hovingh, Milana Ivkovic, Larry Lo, Douglas Kling, Pablo Pergola, Dominic Raj,[...]. Lancet 2021
54
7


Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week.
Peter Libby, Joseph Loscalzo, Paul M Ridker, Michael E Farkouh, Priscilla Y Hsue, Valentin Fuster, Ahmed A Hasan, Salomon Amar. J Am Coll Cardiol 2018
236
4

C-reactive protein levels and outcomes after statin therapy.
Paul M Ridker, Christopher P Cannon, David Morrow, Nader Rifai, Lynda M Rose, Carolyn H McCabe, Marc A Pfeffer, Eugene Braunwald. N Engl J Med 2005
4

Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.
Yuqing Huo, Andreas Schober, S Bradley Forlow, David F Smith, Matthew Craig Hyman, Steffen Jung, Dan R Littman, Christian Weber, Klaus Ley. Nat Med 2003
759
3


NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis.
Alena Grebe, Florian Hoss, Eicke Latz. Circ Res 2018
266
3

Interleukin-1 beta in coronary arteries of patients with ischemic heart disease.
J Galea, J Armstrong, P Gadsdon, H Holden, S E Francis, C M Holt. Arterioscler Thromb Vasc Biol 1996
233
3

Monocytes in coronary artery disease and atherosclerosis: where are we now?
Angie Ghattas, Helen R Griffiths, Andrew Devitt, Gregory Y H Lip, Eduard Shantsila. J Am Coll Cardiol 2013
214
3

Immune and inflammatory mechanisms of atherosclerosis (*).
Elena Galkina, Klaus Ley. Annu Rev Immunol 2009
963
3

NLRP3 inflammasome activity is negatively controlled by miR-223.
Franz Bauernfeind, Anna Rieger, Frank A Schildberg, Percy A Knolle, Jonathan L Schmid-Burgk, Veit Hornung. J Immunol 2012
290
3

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.
P M Ridker, N Rifai, M Clearfield, J R Downs, S E Weis, J S Miles, A M Gotto. N Engl J Med 2001
3


Atlas of the Immune Cell Repertoire in Mouse Atherosclerosis Defined by Single-Cell RNA-Sequencing and Mass Cytometry.
Holger Winkels, Erik Ehinger, Melanie Vassallo, Konrad Buscher, Huy Q Dinh, Kouji Kobiyama, Anouk A J Hamers, Clément Cochain, Ehsan Vafadarnejad, Antoine-Emmanuel Saliba,[...]. Circ Res 2018
204
3

Single-cell analysis of fate-mapped macrophages reveals heterogeneity, including stem-like properties, during atherosclerosis progression and regression.
Jian-Da Lin, Hitoo Nishi, Jordan Poles, Xiang Niu, Caroline Mccauley, Karishma Rahman, Emily J Brown, Stephen T Yeung, Nikollaq Vozhilla, Ada Weinstock,[...]. JCI Insight 2019
108
3

Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis.
Alyssa M Flores, Niloufar Hosseini-Nassab, Kai-Uwe Jarr, Jianqin Ye, Xingjun Zhu, Robert Wirka, Ai Leen Koh, Pavlos Tsantilas, Ying Wang, Vivek Nanda,[...]. Nat Nanotechnol 2020
68
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.